Infection complications in an unselected cohort of patients with multiple myeloma treated with lenalidomide combinations

European Journal of Haematology

Volumn 89, Issue 3, 2012, Pages 276-277

  Caravita, Tommaso ^a   Offidani, Massimo ^b   Siniscalchi, Agostina ^a   Gentili, Silvia ^b   Caraffa, Patrizia ^b   Perrotti, Alessio ^a   de Fabritiis, Paolo ^a   Leoni, Pietro ^b  

^a S EUGENIO HOSPITAL   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LENALIDOMIDE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADULT; AGED; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CHOLECYSTITIS; DRUG FATALITY; FEVER; HERPES ZOSTER; HUMAN; INFECTION; KIDNEY DYSFUNCTION; LETTER; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; NEUTROPENIA; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SEPTIC SHOCK; UNIVARIATE ANALYSIS;

COHORT STUDIES; HUMANS; INFECTION; MULTIPLE MYELOMA; THALIDOMIDE;

EID: 84865121822     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2012.01814.x     Document Type: Letter

References (5)

1. Quach H, Ritchie D, Stewart AK, Neeson P, Harrison S, Smyth MJ, Prince HM. Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myelomaImmunomodulatory drugs in Myeloma. Leukemia 2010;24:22-32.
2. Dimopoulos MA, Palumbo A, Attal M, et al. Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement. Leukemia 2011;25:749-60.
3. Palumbo A, Mateos MV, Bringhen S, San Miguel JF. Practical management of adverse events in multiple myeloma: can therapy be attenuated in older patients? Blood Rev 2011;25:181-91.
4. Nucci M, Anaissie E. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis 2009;49:1211-25.
5. Offidani M, Corvatta L, Polloni C, et al.Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide. Leuk Lymphoma 2011;52:776-85.